Genesco Inc. shareholders voted Tuesday to re-elect all nine incumbent directors at the company's annual meeting, closing a proxy contest that threatened to reshape oversight of the $1.4 billion Nashville-based footwear and accessories retailer. The vote margin has not been disclosed, but the clean sweep leaves Chairman Marty Dickens and CEO Mimi Vaughn with full board continuity heading into the second half of fiscal 2025.
The contest arrived after months of pressure from an unnamed activist holder seeking representation. Proxy advisors split: ISS backed the incumbent slate in its final recommendation issued April 28, while Glass Lewis supported two dissident nominees in a May 2 report. Egan-Jones sided with management. The divergence suggested institutional investors faced a choice between Genesco's multi-year repositioning around its Journeys and Johnston & Murphy banners versus the activist's argument for accelerated portfolio rationalization. Voter turnout is expected to exceed 75% of outstanding shares, typical for contested elections at mid-cap retailers.
The outcome matters because Genesco operates in a sector where board composition directly influences capital allocation speed. The company holds 428 Journeys stores, 156 Johnston & Murphy locations, and 86 Schuh shops across North America and the U.K., with a lease portfolio carrying $312 million in present-value obligations as of February 1. The retained board has spent eighteen months closing underperforming Journeys units and shifting square footage toward off-mall formats, a strategy that improved four-wall EBITDA margins by 190 basis points year-over-year in Q4 fiscal 2024. An activist-influenced board likely would have pushed for faster footprint reduction and explored strategic alternatives for Schuh, the U.K. operation that contributed $18 million in operating losses last fiscal year.
Investors should now watch three near-term events. First, Genesco will report fiscal Q1 2025 earnings in late May, where consensus expects revenue of $512 million, down 3.2% year-over-year, with guidance for the full fiscal year. Second, the company faces a $150 million term loan maturity in September 2026, and management commentary on refinancing timing will signal confidence in cash generation. Third, any post-meeting activist disclosure of stake size or future intentions must appear within ten days if ownership exceeds 5% under Schedule 13D rules. Silence would indicate the holder either sold down or holds below reporting thresholds.
The board continuity removes one variable, but Genesco still trades at 0.42x trailing twelve-month sales, a 37% discount to the specialty retail peer median, reflecting investor skepticism about the U.K. turnaround and Journeys' exposure to teen discretionary spending.